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Abstract. 
In malaria-endemic areas, Plasmodium falciparum prevalence is often high in young women because of 1) low use 
of insecticide-treated nets before their first pregnancy and 2) acquired immunity, meaning infections are 
asymptomatic and thus untreated. Consequently, a common source of malaria in pregnancy (MiP) may be infected 
women becoming pregnant, rather than pregnant women becoming infected. In this study, prevalence of infection 
was determined by microscopy at first antenatal care (ANC) visit in primigravidae and secundigravidae in Ghana, 
Burkina Faso, Mali, and The Gambia, four countries with strong seasonal variations in transmission. Duration of 
pregnancy spent in the rainy season and other risk factors for infection were evaluated using multivariable Poisson 
regression. We found that the overall prevalence of malaria at first ANC was generally high and increased with time 
spent pregnant during the rainy season: prevalence among those with the longest exposure was 59.7% in Ghana, 
56.7% in Burkina Faso, 42.2% in Mali, and 16.8% in Gambia. However, the prevalence was substantial even among 
women whose entire pregnancy before first ANC had occurred in the dry season: 41.3%, 34.4%, 11.5%, and 7.8%, 
respectively, in the four countries. In multivariable analysis, risk of infection was also higher among primigravidae, 
younger women, and those of lower socioeconomic status, independent of seasonality. High prevalence among 
women without exposure to high transmission during their pregnancy suggests that part of the MiP burden results 
from long-duration infections, including those acquired preconception. Prevention of malaria before pregnancy is 
needed to reduce the MiP burden. 
INTRODUCTION 
Malaria in pregnancy (MiP) is a major public health concern, particularly within sub-Saharan 
Africa, which shoulders a disproportionately large share of the malaria burden.1–3 Within this 
region, up to 9.5 million pregnant women were estimated to be at risk of Plasmodium falciparum 
infection in 2015.4 Infection during pregnancy is not only deleterious to the woman but it also 
puts her fetus at increased risk of adverse outcomes, such as preterm delivery, low birth weight, 
and intrauterine growth restriction.5–8 Recommended strategies to prevent and treat MiP include 
free distribution of nets through antenatal care (ANC) and intermittent preventive treatment 
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(IPTp), which involves providing a dose of sulfadoxine–pyrimethamine (SP) to pregnant women 
at each ANC visit during the second and third trimesters of their pregnancy.9 However, neither of 
these interventions takes place until a woman reaches ANC, which can leave her unprotected for 
almost the first half of her pregnancy. Given the burden of MiP, which in some countries has 
persisted despite the scaling-up of IPTp and delivery of nets, there remains a need to identify 
women at greatest risk to inform additional interventions.9,10 
It has recently been suggested that a large percentage of malaria infections carried in early 
pregnancy reflect infections acquired before conception (i.e., the order of events being infected 
women become pregnant, rather than pregnant women become infected).11 Evidence from such 
models are supported by a number of well-known features of malaria epidemiology in high 
transmission areas, including a very high prevalence of malaria infection often observed at first 
ANC visit,12 high prevalence of asymptomatic (and thus untreated) infections in adolescents and 
young women (i.e., the source population for pregnancies),13,14 and low bed net use among 
young women—particularly before first pregnancy when nets are distributed through ANC.13,15 
Identifying whether infections observed during pregnancy result from infections acquired 
before pregnancy, or since conception, may have important implications for malaria control.16 If 
infections acquired preconception are an important source of MiP, then it will be necessary to 
target nonpregnant women to reduce the risk of MiP, and its associated burden, in these women. 
However, estimating when malaria infections were acquired, and their duration, is difficult in 
practice. Areas of highly seasonal malaria transmission, such as the Sahel region of sub-Saharan 
Africa, where infection risk is largely confined to a few months each year, provide an 
opportunity to examine this issue.17 In such settings, there is a well-established association 
between seasonality and malaria risk,18–20 and the timing of the malaria season is well 
defined.20,21 Therefore, depending on the time of conception and the time of first ANC contact, it 
can be inferred with a reasonable degree of certainty whether women have spent all, some, or 
none of their pregnancy exposed to high levels of malaria transmission. Although transmission of 
malaria does not entirely stop during the dry season, if prevalence at the first ANC visit is still 
high among women who have been exposed only to low levels of transmission since they 
became pregnant, this could suggest that infections are acquired preconception (during the peak 
season). Such infections are likely to have been carried until first presentation at an ANC, which 
is usually a woman’s first opportunity to receive a curative course of IPTp. 
In this study, we estimate the prevalence of MiP in four areas of highly seasonal malaria 
transmission in West Africa (Burkina Faso, The Gambia, Ghana, and Mali). We investigate risk 
factors for infection and evidence for carriage of infections acquired before pregnancy until the 
time of first ANC contact. The implications our findings may have on when, and for whom, 
additional MiP interventions could be introduced are discussed. 
METHODS 
Data collection and study sites. 
This study uses data collected from a multicenter, individually randomized, noninferiority 
trial conducted in Burkina Faso, The Gambia, Ghana, and Mali. Details of the methods used in 
the trial have been presented previously.12 In brief, 5,354 primigravid or secundigravid women 
who attended their first ANC visit between May 2010 and October 2011 were randomized to 
receive either IPTp or intermittent screening and treatment (ISTp) on up to three occasions 
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during their pregnancy. Women were followed until approximately 6 weeks postpartum, and a 
number of pregnancy outcomes were recorded. The study sites were Navrongo, Ghana; Ziniaré, 
Burkina Faso; Kita, Yirimadjo and San, Mali; and Bassé, The Gambia (Figure 1). The duration 
and timing of the wet and dry seasons vary between these sites, with corresponding differences 
in the length of the malaria high transmission season. Typically, malaria transmission peaks 
between June and November (i.e., 6 months) in Navrongo, between July and November (i.e., 5 
months) in Burkina Faso and Mali, and between August and November (i.e., 3–4 months) in The 
Gambia. Although there is some year-to-year variation in the onset of the rainy season each year, 
there were no major departures from the typical seasonal pattern reported in any center over the 
study period. Transmission is relatively low at each site during the rest of the year.22 For 
instance, in Navrongo, the site with the longest season, transmission as measured by the 
entomological inoculation rate (EIR) has been shown to fall to very close to zero during the dry 
season, from a peak of between four and six infectious bites per day during the rainy season.23 
The present analysis uses data collected from women attending an ANC clinic for the first 
time between 16 and 30 weeks of gestation. At this baseline visit, biological, social, and 
demographic characteristics were recorded, and a blood sample was obtained. Blood films were 
examined for malaria parasites by two independent readers, with discrepancies resolved using 
standardized methods.24 Nonfalciparum malaria is very rare in these countries.25 The blood film 
was defined as positive if any form of P. falciparum was observed, otherwise it was considered 
negative. 
Data analysis. 
For each woman, the month of conception was estimated based on the date of the first ANC 
visit and the woman’s estimated gestational age, as measured by symphysis-fundal height.12 The 
duration of pregnancy occurring in the rainy season before the first ANC visit was calculated to 
estimate the number of months of high malaria risk to which each woman had been exposed, 
based on the seasonal patterns described above (see Supplemental Figure 1). Consequently, the 
number of months of pregnancy exposed to high transmission ranged from 0 to 6 months in 
Ghana, from 0 to 5 months in Burkina Faso and Mali, and from 0 to 4 months in The Gambia. 
Data on participants’ durable household assets and amenities (see Supplemental Text 1) were 
used to create socioeconomic status (SES) quintiles separately within each country using 
principal components analysis.12 
In each country, sociodemographic and biological risk factors for P. falciparum infection 
were investigated, as well as the change in P. falciparum prevalence by month and by duration of 
pregnancy in the rainy season. Crude prevalence ratios (PRs) were calculated for malaria 
infection by each risk factor using Poisson regression with robust standard errors, as described 
previously.26 Multivariable models were then built for each country to obtain adjusted PRs with 
95% confidence intervals (CIs), adjusted for potential confounding from other risk factors. We 
present results from all countries in the order of Ghana, Burkina Faso, Mali, and The Gambia, 
which correspond approximately to increasing seasonality and reducing transmission intensity. 
All analyses were conducted in Stata 13.0 (StataCorp, College Station, TX). 
Ethics. 
The IPTp–ISTp trial received ethical approval from the committees of each of the 
participating African institutions (see Supplemental Text 2) as well as by the ethics committee of 
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The London School of Hygiene and Tropical Medicine (LSHTM). The trial organizers obtained 
informed, written consent from all participants. The current study received separate ethical 
approval from The LSHTM Ethics Committee. 
RESULTS 
Population characteristics and prevalence. 
Blood smear results were available at baseline for 5,237 women: 1,301 from Ghana, 1,434 
from Burkina Faso, 1,308 from Mali, and 1,194 from The Gambia. In each country, those aged 
between 18 and 20 years accounted for the largest group. Primigravid women represented 
slightly over half of women enrolled, except in Burkina Faso where most of them were 
secundigravid. Bed net use at first ANC visit varied greatly between settings, with Ghanaian 
women reporting the lowest frequency of net use (37.4%) and Gambian women the highest 
(81.7%) (Tables 1–4). However, in all four countries, we found evidence of higher net use during 
second pregnancies (Ghana: primigravid [29.3%] versus secundigravid [47.6%]; Burkina Faso: 
48.0% versus 59.8%; Mali 56.0% versus 69.7%; The Gambia: 82.3% versus 86.8%). Further 
analysis of net use by age and gravidity are shown in Supplemental Figure 2. 
The overall prevalence of malaria at first ANC visit was 48.0% (95% CI: 45.2–50.7) in 
Ghana, 42.0% (95% CI: 39.4–44.5) in Burkina Faso, 21.7% (95% CI: 19.5–23.9) in Mali, and 
8.8% (95% CI: 7.2–10.4) in The Gambia. When estimated by month of ANC attendance, 
prevalence was greatest in the late wet season and early dry season months in each country 
(Figure 2). In all four countries, prevalence increased with greater duration of pregnancy in the 
rainy season, among those having the longest exposure prevalence was 59.7% (95% CI: 46.5–
72.8), 56.7% (95% CI: 49.4–64.0), 42.2% (95% CI: 31.8–52.6), and 16.8% (95% CI: 11.7–22.0), 
respectively (Figure 3). Prevalence was still substantial among women whose entire pregnancy 
before first ANC visit had occurred in the dry season (i.e., 0 months in high transmission 
season): 41.3% (95% CI: 34.1–48.5) in Ghana, 34.4% (95% CI: 28.6–40.1) in Burkina Faso, 
11.5% (95% CI: 8.1–14.9) in Mali, and 7.8% (95% CI: 5.4–10.2) in The Gambia (Tables 1–4). 
Risk factors for MiP. 
In crude analyses, there were very strong associations in all countries between malaria 
infection on presentation at ANC and the duration of pregnancy spent in the rainy season, as well 
as age and gravidity. Women whose entire pregnancy up to their first presentation at ANC had 
taken place during the rainy season were at greater risk of malaria than those whose entire 
pregnancy had taken place during the dry season (Ghana PR: 1.44, 95% CI: 1.10–1.90, P < 
0.001; Burkina PR: 1.65, 95% CI: 1.34–2.04, P < 0.001; Mali PR: 3.67, 95% CI: 2.51–5.38, P < 
0.001; Gambia PR: 2.16, 95% CI: 1.41–3.31, P < 0.001). The prevalence of infection at first 
ANC visit was also greatest in younger mothers (decreasing with increasing age), and was 
greater among primigravid women as compared with secundigravid women. In addition, there 
was strong evidence of an association between lower SES and greater prevalence of infection in 
Ghana, Mali, and The Gambia; however, this was not seen in Burkina Faso (Tables 1–4). 
Women presenting to ANC at later gestational ages were at lower risk of malaria than those 
presenting earlier, and bed net use was not strongly associated with malaria prevalence in crude 
analyses. 
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After adjusting for each of these factors (i.e., age, gravidity, gestational age, SES, net use, 
and duration of pregnancy in the rainy season) in multivariable models, the association between 
malaria and duration of pregnancy in the rainy season remained very strong in all four countries. 
The prevalence of infection among those whose pregnancy spanned the entire rainy season was 
1.48 (95% CI: 1.13–1.95, P < 0.001) times that of the prevalence among those whose pregnancy 
spanned the dry season in Ghana, 1.85 (95% CI: 1.50–2.29, P < 0.001) times in Burkina Faso, 
3.16 (95% CI: 2.12–4.70, P < 0.001) times in Mali, and 2.24 (95% CI: 1.45–3.47, P < 0.001) 
times in The Gambia. 
After adjustment, other well-known risk factors for MiP, including young maternal age and 
primigravidity, remained associated with infection (Tables 1–4). We observed a lower 
prevalence of infection among nonbed net users in Ghana (PR compared with net users: 0.85, 
95% CI: 0.76–0.96, P = 0.01) (Table 1), but no association between net use and infection in 
Burkina Faso, Mali, and The Gambia after adjustment (Tables 2–4). 
DISCUSSION 
In areas of seasonal malaria transmission in Ghana, Burkina Faso, Mali, and The Gambia, the 
prevalence of malaria infection at the time of first ANC contact in pregnancy was generally high, 
with two countries having prevalence of infection more than 40% by microscopy. The risk of 
infection was found to increase markedly as the number of months of pregnancy that had 
occurred in the rainy season before attending ANC increased, with women whose pregnancies 
spanned most of the rainy season at the highest risk. 
Given the well-known seasonal fluctuations in infection risk in West Africa,17–19 increasing 
risk with increasing time spent exposed during the rainy season is not unexpected. However, an 
important finding, which has been much less well described, was that women whose pregnancy 
until first ANC contact had occurred largely—or entirely—in the dry season were still at 
substantial risk of carrying infections in pregnancy. This was particularly the case in the two high 
transmission countries studied, Ghana and Burkina Faso, where women who carried none of 
their pregnancy in the wet season up to their first ANC visit still had a malaria prevalence of 30–
40%. New infections are unlikely to explain such a high prevalence, given the low risk of 
infection in the months leading up to these women attending ANC. Consequently, it is likely that 
the majority of these infections were acquired before pregnancy in a previous transmission 
season, and retained until, and also during, the woman’s current pregnancy. A previous modeling 
study by Walker et al.11 suggested that in all but the very highest transmission settings, more than 
50% of the time spent infected in pregnancy results from infections acquired before development 
of the placenta, with the majority of these infections acquired pre-pregnancy. The impact of these 
retained infections, which is mirrored in all four countries with different seasonal transmission 
patterns, has not yet been well described. However, there is increasing evidence of the 
deleterious effects of malaria in the first trimester, including its impact on development of the 
placenta.27 This impact may be substantial, given both the high prevalence of infection and the 
likelihood that if these infections were acquired before pregnancy, they have lasted for several 
months, thus spanning the entire first trimester and part of the second trimester. 
In all four countries, the risk of malaria was also found to be greatest among women in their 
first pregnancy, younger women, those presenting at an earlier gestational age, as well as those 
of lower SES, with these factors remaining associated with infection in multivariable analyses. 
These factors are consistent with results found in other seasonal,18,28,29 as well as nonseasonal, 
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settings such as Mozambique30 and Gabon.17 We also found that net use was not associated with 
prevalence, except in Ghana where nonusers had lower prevalence (potentially because current 
net use may be a marker of living in areas with higher biting rates, and consequently higher 
malaria risk). 
Currently, the World Health Organization (WHO) recommends universal bed net coverage to 
prevent malaria across sub-Saharan Africa, but the usage has consistently been found to be 
lowest in adolescents and young adults.14,31 The WHO’s pregnancy-specific recommendations 
include 1) effective case management of clinical malaria, 2) IPTp with SP at each ANC contact 
after the first trimester of pregnancy, and 3) provision of insecticide-treated bed nets at ANC.9 
However, the women most likely to be infected, and those most likely to suffer negative 
consequences of MiP—young, primigravid women—will likely not benefit from these strategies 
until they first contact ANC.13,14 The observed high prevalence suggests that relatively few 
women develop clinical malaria and receive effective treatment. Infected women will benefit 
from having their infections cleared by IPTp with SP, but the full benefit of chemoprevention 
may not be realized if pregnant women have already spent the first part of their pregnancy—
perhaps more than half of the total gestation period—infected. Likewise, bed nets delivered at 
first ANC visit will provide protection for the remainder of a woman’s current pregnancy and in 
subsequent pregnancies if nets are retained.15,32 However, this leaves primigravid women, who 
are already at higher risk, unprotected until first ANC. This was reflected within our dataset, with 
higher net use during second pregnancies in all four countries. 
Our results therefore emphasize the need for enhanced and effective prevention either at an 
earlier stage of pregnancy or before pregnancy—perhaps by measures targeting all women of 
child-bearing age or young women and adolescent girls. For instance, pre-pregnancy 
interventions could include net delivery campaigns targeting this population (i.e., young women 
or all women of child-bearing age), presumptive treatment, or perhaps rapid diagnostic test 
(RDT)–based screening aiming to reduce the infectious reservoir in young women. Seasonally 
targeted MiP interventions during early pregnancy have also been suggested as a way to meet the 
different needs of women in seasonal settings. These could include enhanced IPTp, seasonal 
drives to increase net coverage, and potentially even seasonal vaccination of pregnant women 
with RTS,S/AS01, provided the vaccine is found to be nonteratogonic.33 
Although our study evaluates the prevalence of, and risk factors for, MiP in four West 
African countries, several limitations of the design should be noted. First, it is not necessarily the 
case that there is no malaria transmission during the dry season, particularly in areas where 
prevalence is higher, and thus where residual transmission in the dry season may be greater. 
Consequently, a small percentage of infections seen in women only pregnant during the dry 
season may result from recent infection. However, we consider it unlikely that the high 
prevalence observed (particularly in Ghana and Burkina Faso) can result only from recent 
infections. Although out of the scope of our analysis, this could be further examined empirically 
in a prospective study, perhaps by following women from marriage into first pregnancy and 
typing their parasites by molecular markers. Secondly, our study design is a cross-sectional 
analysis of baseline data of women enrolled in a multicenter trial. Primigravid or secundigravid 
women attending ANC for the first time were enrolled with relatively few exclusion criteria (i.e., 
a severe chronic infection, known allergy to SP, prior receipt of SP during their pregnancy, or an 
intention to leave the study area), and with less than 200 refusals among more than 6,500 women 
screened.12 However, this is not a truly random sample of all ANC attendees. Given the findings 
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in relation to SES in this study, and more generally, we speculate that prevalence may be even 
greater if we could include women unable to attend ANC, or any women who suffered a 
miscarriage as a result of their infection early in pregnancy and who consequently never attended 
ANC. 
In this study, bed net use was defined as whether women reported sleeping under a net the 
night before their first ANC visit. A possible limitation of our study is that, although this 
question is widely used and validated, net use at the time of first ANC contact does not 
necessarily represent the net use at the etiologically relevant time (when the women actually 
became infected). In addition, we recognize that our measures of gestational age by symphysis-
fundal height may not be as robust as methods such as ultrasound, which were not available in 
these settings. However, given that women had repeated contact with ANC until delivery, the 
gestational age estimates were crosschecked with measurements taken at the later contacts, and 
any woman with inconsistent estimates of gestational age were set to missing and therefore not 
included in our analysis.12 Furthermore, our results, based on microscopy, may be somewhat 
conservative in terms of the overall burden that might have been detected by molecular methods. 
A study by Williams et al.34 which analyzed samples from half the women enrolled in this study 
using polymerase chain reaction, indicated that although the sensitivity of microscopy and RDT 
were high in paucigravid women, additional lower density infections were still missed. However, 
these additional low-density infections may be of less concern with respect to outcomes of 
pregnancy.35 
CONCLUSIONS 
We found a substantial burden of malaria infection at the time of first contact with ANC 
among primigravid and secundigravid women in West Africa. Although there is evidence of 
increasing prevalence among women whose pregnancy occurs during the rainy season, even 
women pregnant at a time of low immediate risk had high rates of parasite carriage, likely due to 
infections acquired before their pregnancy. Additional strategies are needed to prevent MiP, but 
for maximum impact, these will need to address infections acquired before pregnancy and 
carried during the first months of pregnancy before contact with ANC. 
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pregnancy in the rainy season in Ghana, Burkina Faso, Mali, and The Gambia. This figure appears in color at 
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TABLE 1 
Distribution of risk factors, crude and adjusted prevalence ratios for malaria in pregnancy in Ghana (crude N = 
1,301; adjusted N = 1,293) 
Variable Frequency (%) 
% 
Plasmodium 
falciparum 
infection 
Crude PR* 
(95% CI) P value† 
Adjusted PR‡ 
(95% CI) P value† 
Months pregnant in rainy season   < 0.001  < 0.001 
 0 months 184 (14.1) 41.3 ref – ref – 
 1 months 277 (21.3) 33.2 
0.80 (0.63–
1.02) 
– 0.86 (0.68–
1.08) 
– 
 2 months 215 (16.5) 44.7 
1.08 (0.86–
1.36) 
– 1.11 (0.89–
1.39) 
– 
 3 months 212 (16.3) 60.4 
1.46 (1.19–
1.79) 
– 1.47 (1.21–
1.78) 
– 
 4 months 190 (14.6) 61.6 
1.49 (1.21–
1.83) 
– 1.50 (1.23–
1.82) 
– 
 5 months 166 (12.8) 48.8 
1.18 (0.94–
1.49) 
– 1.20 (0.96–
1.50) 
– 
 6 months 57 (4.4) 59.7 
1.44 (1.10–
1.90) 
– 1.48 (1.13–
1.95) 
– 
Age    < 0.001  < 0.001 
 25 years + 273 (21.0) 34.4 ref – ref – 
 21–24 years 407 (31.3) 36.9 1.07 (0.87–1.32) 
– 1.03 (0.84–
1.27) 
– 
 18–20 years 531 (40.8) 60.1 1.74 (1.46–2.08) 
– 1.51 (1.25–
1.84) 
– 
 Under 18 years 90 (6.9) 67.8 1.97 (1.58–2.45) 
– 1.55 (1.23–
1.97) 
– 
Gravidity§    < 0.001  < 0.001 
 Secundigravid 575 (44.2) 37.7 ref – ref – 
 Primigravid 723 (55.6) 56.0 1.48 (1.31–1.68) 
– 1.29 (1.13–
1.48) 
– 
Gestational age    0.08  0.02 
 < 20 weeks 567 (43.6) 47.8 ref – ref – 
 20–24 weeks 602 (46.3) 50.2 1.05 (0.93–1.18) 
– 1.01 (0.90–
1.13) 
– 
 25–30 weeks 132 (10.1) 38.6 0.81 (0.64–1.02) 
– 0.74 (0.59–
0.92) 
– 
Socio-economic 
status§    < 0.001  0.15 
 Least poor 262 (20.1) 37.0 ref – ref – 
 Less poor 260 (20.0) 48.9 1.32 (1.08–1.61) 
– 1.20 (0.98–
1.45) 
– 
 Middle 274 (21.1) 46.4 1.25 (1.02–1.53) 
– 1.10 (0.90–
1.34) 
– 
 More poor 246 (18.9) 51.2 1.38 (1.13–1.69) 
– 1.19 (0.98–
1.44) 
– 
 Most poor 255 (19.6) 56.5 1.53 (1.26–1.85) 
– 1.26 (1.04–
1.53) 
– 
Bed net use previous 
night§    0.05  0.01 
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 Yes 487 (37.4) 51.5 ref – ref – 
 No 813 (62.5) 45.9 0.89 (0.79–1.00) 
– 0.85 (0.76–
0.96) 
– 
CI = confidence interval; PR = prevalence ratio. 
* Crude PRs calculated from univariate Poisson regression. 
† P values obtained from Wald’s test. Comparisons restricted to observations without missing data for variables 
listed. 
‡ Adjusted PRs calculated using Poisson regression, adjusting for all other variables listed in the table. 
§ Missing values for gravidity N = 3 (0.2%); SES N = 4 (0.3%); bed net use N = 1 (0.1%). 
TABLE 2 
Distribution of risk factors, crude and adjusted prevalence ratios for malaria in pregnancy in Burkina Faso (crude N 
= 1,434; adjusted N = 1,330) 
Variable Frequency (%) 
% 
Plasmodium 
falciparum 
infection 
Crude PR* 
(95% CI) P value† 
Adjusted PR‡ 
(95% CI) P value† 
Months pregnant in rainy season§   < 0.001  < 0.001 
 0 months 262 (18.3) 34.4 ref – ref – 
 1 months 287 (20.0) 27.9 
0.81 (0.63–
1.04) 
– 0.87 (0.68–
1.13) 
– 
 2 months 272 (19.0) 43.8 
1.27 (1.03–
1.58) 
– 1.38 (1.11–
1.71) 
– 
 3 months 207 (14.4) 44.0 
1.28 (1.02–
1.61) 
– 1.34 (1.06–
1.68) 
– 
 4 months 205 (14.3) 53.7 
1.56 (1.27–
1.93) 
– 1.70 (1.38–
2.10) 
– 
 5 months 180 (12.6) 56.7 
1.65 (1.34–
2.04) 
– 1.85 (1.50–
2.29) 
– 
Age    < 0.001  < 0.001 
 25 years+ 131 (9.1) 23.7 ref – ref – 
 21–24 years 433 (30.2) 29.1 1.23 (0.87–1.73) 
– 1.25 (0.88–
1.76) 
– 
 18–20 years 855 (59.6) 51.0 2.15 (1.57–2.95) 
– 1.81 (1.30–
2.53) 
– 
 Under 18 years 15 (1.1) 60.0 2.54 (1.51–4.24) 
– 1.67 (0.73–
3.82) 
– 
Gravidity§    < 0.001  < 0.001 
 Secundigravid 750 (52.3) 30.4 ref – ref – 
 Primigravid 663 (46.2) 54.9 1.81 (1.59–2.05) 
– 1.43 (1.24–
1.65) 
– 
Gestational age§    0.003  0.002 
 < 20 weeks 489 (34.1) 47.0 ref – ref – 
 20–24 weeks 750 (52.3) 40.8 0.87 (0.76–0.99) 
– 0.85 (0.75–
0.96) 
– 
 25–30 weeks 174 (12.1) 32.2 0.68 (0.54–0.87) 
– 0.69 (0.55–
0.88) 
– 
Socio-economic 
status§    0.35  0.16 
 Least poor 280 (19.5) 41.8 ref – ref – 
Page 13 of 21 
 Less poor 264 (18.4) 41.7 1.00 (0.82–1.22) 
– 0.92 (0.76–
1.11) 
– 
 Middle 281 (19.6) 45.2 1.08 (0.90–1.31) 
– 1.02 (0.85–
1.21) 
– 
 More poor 266 (18.6) 45.1 1.08 (0.89–1.31) 
– 1.03 (0.86–
1.24) 
– 
 Most poor 270 (18.8) 37.4 0.90 (0.73–1.10) 
– 0.83 (0.68–
1.01) 
– 
Bed net use previous 
night§    0.06  0.10 
 Yes 769 (53.6) 39.9 ref – ref – 
 No 651 (45.4) 44.9 1.12 (0.99–1.27) 
– 1.11 (0.98–
1.25) 
– 
CI = confidence interval; PR = prevalence ratio. 
* Crude PRs calculated from univariate Poisson regression. 
† P values obtained from Wald’s test. Comparisons restricted to observations without missing data for variables 
listed. 
‡ Adjusted PRs calculated using Poisson regression, adjusting for all other variables listed in the table. 
§ Missing values for season N = 21 (1.5%); gravidity N = 21 (1.5%); gestational age (1.5%); SES N = 73 (5.1%); 
bed net use N = 14 (1.0%). 
TABLE 3 
Distribution of risk factors, crude and adjusted prevalence ratios for malaria in pregnancy in Mali (crude N = 1,308; 
adjusted N = 1,258) 
Variable Frequency (%) 
% 
Plasmodium 
falciparum 
infection 
Crude PR* 
(95% CI) 
P 
value†* 
Adjusted PR‡ 
(95% CI) P value† 
Months pregnant in rainy season   < 0.001  < 0.001 
 0 months 339 (25.9) 11.5 ref – ref – 
 1 months 283 (21.6) 14.5 
1.26 (0.84–
1.90) 
– 1.19 (0.79–
1.79) 
– 
 2 months 263 (20.1) 24.3 
2.12 (1.47–
3.04) 
– 1.98 (1.37–
2.87) 
– 
 3 months 168 (12.8) 21.4 
1.86 (1.23–
2.82) 
– 1.66 (1.09–
2.51) 
– 
 4 months 165 (12.6) 40.0 
3.48 (2.45–
4.93) 
– 2.81 (1.97–
4.01) 
– 
 5 months 90 (6.9) 42.2 
3.67 (2.51–
5.38) 
– 3.16 (2.12–
4.70) 
– 
Age    0.002  0.004 
 25 years+ 107 (8.2) 11.2 ref – ref – 
 21–24 years 243 (18.6) 16.5 1.47 (0.80–2.68) 
– 1.57 (0.87–
2.84) 
– 
 18–20 years 606 (46.3) 25.7 2.30 (1.32–3.98) 
– 2.00 (1.16–
3.45) 
– 
 Under 18 years 352 (26.9) 21.6 1.93 (1.09–3.40) 
– 1.42 (0.80–
2.52) 
– 
Gravidity    < 0.001  < 0.001 
 Secundigravid 512 (39.1) 14.8 ref – ref – 
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 Primigravid 796 (60.9) 26.1 1.76 (1.39–2.23) 
– 1.71 (1.32–
2.20) 
– 
Gestational age    0.32  0.27 
 < 20 weeks 430 (32.9) 22.8 ref – ref – 
 20–24 weeks 771 (58.9) 21.9 0.96 (0.77–1.20) 
– 0.93 (0.75–
1.16) 
– 
 25–30 weeks 107 (8.2) 15.9 0.70 (0.44–1.11) 
– 0.69 (0.43–
1.08) 
– 
Socio-economic 
status§    < 0.001  < 0.001 
 Least poor 256 (19.6) 12.9 ref – ref – 
 Less poor 252 (19.3) 12.3 0.95 (0.60–1.51) 
– 0.87 (0.56–
1.36) 
– 
 Middle 257 (19.7) 22.6 1.75 (1.18–2.59) 
– 1.41 (0.95–
2.10) 
– 
 More poor 259 (19.8) 26.6 2.07 (1.42–3.01) 
– 1.62 (1.11–
2.36) 
– 
 Most poor 249 (19.0) 35.3 2.74 (1.91–3.93) 
– 2.01 (1.39–
2.90) 
– 
Bed net use previous 
night§    0.19  0.26 
 Yes 789 (60.3) 20.5 ref – ref – 
 No 496 (37.9) 23.6 1.15 (0.93–1.42) 
– 1.12 (0.92–
1.37) – 
CI = confidence interval; PR = prevalence ratio. 
* Crude PRs calculated from univariate Poisson regression. 
† P values obtained from Wald’s test. Comparisons restricted to observations without missing data for variables 
listed. 
‡ Adjusted PRs calculated using Poisson regression, adjusting for all other variables listed in the table. 
§ Missing values for SES N = 35 (2.7%); bed net use N = 23 (1.8%). 
TABLE 4 
Distribution of risk factors, crude and adjusted prevalence ratios for malaria in pregnancy in The Gambia (crude N = 
1,194; adjusted N = 1,113) 
Variable Frequency (%) 
% 
Plasmodium 
falciparum 
infection 
Crude PR* 
(95% CI) P value† 
Adjusted PR‡ 
(95% CI) P value† 
Months pregnant in rainy season   < 0.001  < 0.001 
 0 months 500 (41.9) 7.8 ref – ref – 
 1 months 201 (16.8) 6.0 
0.77 (0.41–
1.43) 
– 0.74 (0.39–
1.40) 
– 
 2 months 128 (10.7) 6.3 
0.80 (0.38–
1.67) 
– 0.82 (0.37–
1.86) 
– 
 3 months 157 (13.2) 7.0 
0.90 (0.47–
1.71) 
– 1.00 (0.54–
1.84) 
– 
 4 months 208 (17.4) 16.8 
2.16 (1.41–
3.31) 
– 2.24 (1.45–
3.47) 
– 
Age    < 0.001  0.05 
 25 years+ 121 (10.1) 6.6 ref – ref – 
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 21–24 years 287 (24.0) 8.4 1.26 (0.58–2.74) 
– 1.03 (0.49–
2.19) 
– 
 18–20 years 569 (47.7) 6.7 1.01 (0.48–2.11) 
– 0.77 (0.38–
1.59) 
– 
 Under 18 years 217 (18.2) 16.1 2.44 (1.17–5.09) 
– 1.52 (0.70–
3.31) 
– 
Gravidity    0.03  0.06 
 Secundigravid 520 (43.5) 6.7 ref – ref – 
 Primigravid 674 (56.5) 10.4 1.54 (1.05–2.28) 
– 1.54 (0.98–
2.43) 
– 
Gestational age    0.001  < 0.001 
 < 20 weeks 394 (33.0) 12.9 ref – ref – 
 20–24 weeks 652 (54.6) 7.4 0.57 (0.39–0.83) 
– 0.49 (0.33–
0.71) 
– 
 25–30 weeks 148 (12.4) 4.1 0.31 (0.14–0.71) 
– 0.32 (0.14–
0.73) 
– 
Socioeconomic status§    0.01  0.001 
 Least poor 228 (19.1) 4.4 ref – ref – 
 Less poor 232 (19.4) 5.6 1.28 (0.57–2.86) 
– 1.31 (0.59–
2.91) 
– 
 Middle 222 (18.6) 9.5 2.16 (1.04–4.48) 
– 1.92 (0.93–
3.98) 
– 
 More poor 224 (18.8) 12.1 2.75 (1.36–5.55) 
– 2.96 (1.45–
6.04) 
– 
 Most poor 211 (17.7) 12.8 2.92 (1.45–5.88) 
– 3.36 (1.66–
6.77) 
– 
Bed net use previous 
night§    0.61  0.36 
 Yes 976 (81.7) 8.7 ref – ref – 
 No 182 (15.2) 9.9 1.14 (0.70–1.84) 
– 1.25 (0.78–
2.01) 
– 
CI = confidence interval; PR = prevalence ratio. 
* Crude PRs calculated from univariate Poisson regression. 
† P values obtained from Wald’s test. Comparisons restricted to observations without missing data for variables 
listed. 
‡ Adjusted PRs calculated using Poisson regression, adjusting for all other variables listed in the table. 
§ Missing values for SES N = 77 (6.4%); bed net use N = 36 (3.0%). 
SUPPLEMENTAL FIGURE 1. Illustration of the duration of pregnancy in the rainy season measure in Ghana. NB: 
Estimated date of conception calculated from gestational age measure in weeks (measured by symphysis-fundal 
height). 
SUPPLEMENTAL TEXT 1 
Household assets and amenities used to create socioeconomic status quintiles. 
The wealth index was based on the following durable household assets and amenities: 
drinking water source; type of toilet facility; cooking fuel; type of flooring; type of roofing; 
household electrification; and ownership of a radio, television, fixed telephone, refrigerator, 
mobile phone, bicycle, scooter, car, ox-cart, and animals (chicken, ducks, goats). 
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SUPPLEMENTAL TEXT 2 
Ethical approval committees. 
Country Ethics committee 
Burkina Faso Comité national d’ethique pour la recherché en santé (CNERS) Ministère de la 
Santé, BP 7009, Ouagadougou 03, Burkina Faso 
The Gambia The Gambia Government/MRC laboratories Joint Ethics Committee, C/O MRC 
Laboratories, Fajara, P. O. Box 273 Banjul, The Gambia 
Ethics committee of the Ghana Health Service Committee Research & 
Development Division, Ghana Health Science, P. O. Box 190, Accra, Ghana 
Ghana 
Navrongo Health Research Center Institutional Review Board, Navrongo Health 
Research Center, P. O. Box 114, Navrongo, Ghana 
Mali Ethics committee of the Ministere de l’Enseignement Superieur et de la Recherche 
Scientifique Universite de Bamako-BP 1805- Bamako, Mali 
SUPPLEMENTAL FIGURE 2. Prevalence of bed net use at first ANC visit by age and gravidity in Burkina Faso, The 
Gambia, Ghana, and Mali. 
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